← All trials
NCT06810869
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 5, 2025
- Primary completion
- Nov 17, 2026
- Completion date
- Nov 17, 2026
- First posted
- Feb 6, 2025
- Last posted
- Feb 6, 2025
- Enrollment
- 29
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Wannan Medical CollegeLead sponsor
- Beijing Konruns Pharmaceutical Co., Ltd.Collaborator
- Wannan Medical CollegeSponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.